DVA · 8-K · 20260804PR000105
Operating Margin Drivers
DAVITA INC. · 2026-08-04 · Importance 42 · Surprise 14 · In source text
Second-quarter operating income increased to $579 million from $538 million in the second quarter of 2025 and $482 million in the first quarter of 2026. Operating margin was 16.3%, compared with 14.1% sequentially and 15.9% in the prior-year quarter based on reported operating income and revenue. U.S. dialysis generated $538 million of operating income, integrated kidney care generated $40 million, international operations generated $25 million, and corporate administrative support reduced operating income by $16 million. U.S. dialysis patient-care costs per treatment fell to $277.40 from $280.11 sequentially because of lower payroll taxes and pharmaceutical costs, partially offset by higher health-benefit expenses and increased treatment volume.
Key facts
- Operating income was $579 million for the quarter ended June 30, 2026. source
- Operating margin (consolidated) was 16.3% for the three months ended June 30, 2026. source
- U.S. dialysis segment operating income was $538 million for the three months ended June 30, 2026. source
- Total consolidated operating income for the six months ended June 30, 2026 was $1,061 million (15.2% margin year-to-date). source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| operating_income | positive | realized | — | Operating income was $579 million for the quarter ended June 30, 2026. |
| margin | positive | realized | — | Operating margin (consolidated) was 16.3% for the three months ended June 30, 2026. |
| operating_income | positive | realized | — | U.S. dialysis segment operating income was $538 million for the three months ended June 30, 2026. |
| operating_income | positive | realized | — | Total consolidated operating income for the six months ended June 30, 2026 was $1,061 million (15.2% margin year-to-date). |